Table 3 Baseline Characteristics of Ischemic Stroke Patients in 2010
Recurrent cerebrovascular event (n = 80) | Non-recurrent cerebrovascular event (n = 386) | P value | CAD (n = 57) | Non-CAD (n = 409) | P value | Death (n = 158) | Survival (n = 308) | P value | |
|---|---|---|---|---|---|---|---|---|---|
Sex | |||||||||
Female (%) | 38 (47.5) | 198 (51.3) | 0.54 | 32(56.1) | 204 (49.9) | 0.38 | 74 (46.8) | 162 (52.6) | 0.24 |
Male (%) | 42 (52.5) | 188 (48.7) | 25 (43.9) | 205(50.1) | 84 (53.2) | 146(47.4) | |||
Age (Years) | 74.0 ± 8.8 | 71.0 ± 11.6 | 0.03 | 76.6 ± 8.9 | 70.6 ± 12.0 | < 0.001 | 77.6 ± 8.1 | 68.4 ± 11.4 | < 0.001* |
BMI (Kg/m2) | 24.2 ± 3.1 | 24.3 ± 3.7 | 0.91 | 23.6 ± 3.9 | 24.3 ± 3.6 | 0.32 | 23.6 ± 3.1 | 24.5 ± 3.8 | 0.06 |
Current smoker (%) | 6 (7.5) | 31 (8.0) | 0.87 | 3 (5.3) | 34 (8.3) | 0.61 | 13 (8.2) | 24 (7.8) | 0.86 |
HT (%) | 71 (88.8) | 331 (85.8) | 0.48 | 53 (93.0) | 349 (85.3) | 0.12 | 138 (87.3) | 264 (85.7) | 0.63 |
SBP (mmHg) | 130.6 ± 14.9 | 130.8 ± 14.9 | 0.94 | 134.7 ± 16.7 | 130.2 ± 14.5 | 0.03 | 132.0 ± 16.8 | 130.1 ± 13.8 | 0.22 |
DBP (mmHg) | 69.1 ± 9.3 | 70.3 ± 10.2 | 0.36 | 70.1 ± 9.9 | 70.1 ± 10.1 | 0.99 | 67.6 ± 9.3 | 71.4 ± 10.2 | < 0.001 |
DM (%) | 28 (35.0) | 108 (28.0) | 0.21 | 16 (28.1) | 120 (29.3) | 0.84 | 48 (30.4) | 88 (28.6) | 0.68 |
HbA1c (%) | 6.7 ± 0.6 | 6.7 ± 1.0 | 0.75 | 6.7 ± 0.9 | 6.6 ± 0.8 | 0.32 | 6.7 ± 1.1 | 6.7 ± 0.9 | 0.74 |
LDL (mmol/L) | 2.9 ± 0.8 | 2.9 ± 0.8 | 0.90 | 2.8 ± 0.6 | 2.9 ± 0.7 | 0.42 | 2.8 ± 0.8 | 2.9 ± 0.7 | 0.36 |
Statin user (%) | 19 (23.8) | 168 (43.5) | 0.001 | 18 (31.6) | 169 (41.3) | 0.16 | 45 (28.5) | 142 (46.1) | < 0.001 |
Atrial fibrillation (%) | 0 | 5 (1.3) | 0.59 | 1 (1.8) | 4 (1.0) | 0.48 | 1 (0.6) | 4 (1.3) | 0.67 |
Antiplatelet treatment (%) | 78 (97.5) | 373 (96.6) | 0.99 | 56 (98.2) | 395(96.6) | 0.50 | 150 (94.9) | 301(97.7) | 0.11 |